Loading clinical trials...
Loading clinical trials...
This study was a French multicentric cross-sectional study retrospectively of 108 consecutive advanced NSCLC patients with a PD-L1 TPS ≥50% and without EGFR/ALK aberrations treated by pembrolizumab in...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Brest
NCT07668037 · Non-Small Cell Carcinoma of Lung, Immunotherapy, and more
NCT06780085 · Carcinoma, Non-Small-Cell Lung
NCT06159335 · Brain Metastasis, Radiation Therapy, and more
NCT07267000 · Non-Small Cell Lung Cancer, Exercise Training, and more
NCT07489066 · Carcinoma, Non-Small-Cell Lung, and more
CHRU de Brest
Brest
CHIC de QUIMPER
Quimper
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions